These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


821 related items for PubMed ID: 22929493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, Hanseman DJ, Robinson BR.
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
    Strom RG, Frempong-Boadu AK.
    Spine (Phila Pa 1976); 2013 Nov 01; 38(23):E1498-502. PubMed ID: 23873245
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury.
    Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, Herrmann D, Peppard W.
    J Am Coll Surg; 2011 Jul 01; 213(1):148-53; discussion 153-4. PubMed ID: 21459632
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB, Pekow PS, Lahti M, Lindenauer PK.
    J Hosp Med; 2012 Jul 01; 7(6):457-63. PubMed ID: 22473716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
    O'Carroll CB, Capampangan DJ, Aguilar MI, Bravo TP, Hoffman-Snyder CR, Wingerchuk DM, Wellik KE, Demaerschalk BM.
    Neurologist; 2011 Jul 01; 17(4):232-5. PubMed ID: 21712672
    [Abstract] [Full Text] [Related]

  • 13. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review.
    Depew AJ, Hu CK, Nguyen AC, Driessen N.
    Am Surg; 2008 Oct 01; 74(10):906-11. PubMed ID: 18942611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
    Blondon M, Perrier A, Nendaz M, Righini M, Boehlen F, Boulvain M, De Moerloose P.
    Thromb Haemost; 2010 Jan 01; 103(1):129-37. PubMed ID: 20062923
    [Abstract] [Full Text] [Related]

  • 16. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN, Cain-Nielsen AH, Jakubus JL, Mikhail JN, Fath JJ, Regenbogen SE, Hemmila MR.
    J Trauma Acute Care Surg; 2017 Jul 01; 83(1):151-158. PubMed ID: 28426561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis.
    Elkbuli A, Watts E, Patel H, Chin B, Wright DD, Inouye M, Nunez D, Rhodes HX.
    J Surg Res; 2024 Aug 01; 300():165-172. PubMed ID: 38815515
    [Abstract] [Full Text] [Related]

  • 19. Venous thromboembolism in cancer patients.
    Deng A, Galanis T, Graham MG.
    Hosp Pract (1995); 2014 Dec 01; 42(5):24-33. PubMed ID: 25485915
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T, Liu X, Edelsberg J, Phatak H, Vera-Llonch M, Liu LZ, Oster G.
    Circ Cardiovasc Qual Outcomes; 2013 Jan 01; 6(1):75-82. PubMed ID: 23300270
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.